OTC Markets OTCQB - Delayed Quote USD
Biotricity, Inc. (BTCY)
0.4600
+0.0100
+(2.22%)
At close: April 25 at 3:56:11 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
12,619.8720
12,063.3450
9,639.0570
7,650.2690
3,384.7670
Cost of Revenue
3,357.2310
3,707.0640
4,197.0240
3,080.1160
2,112.0350
Gross Profit
9,262.6410
8,356.2810
5,442.0330
4,570.1530
1,272.7320
Operating Expense
15,013.2690
17,184.5500
20,851.7440
21,306.9560
14,624.5260
Operating Income
-5,750.6280
-8,828.2690
-15,409.7110
-16,736.8030
-13,351.7940
Net Non Operating Interest Income Expense
-5,629.6680
-5,191.7230
-2,582.6180
-10,569.5930
-2,481.1550
Other Income Expense
-866.5530
-74.2910
-665.8140
-1,824.0810
341.7730
Pretax Income
-12,246.8490
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
Net Income Common Stockholders
-16,047.4200
-14,928.9600
-19,533.6830
-30,219.4540
-16,453.3240
Diluted NI Available to Com Stockholders
-16,047.4200
-14,928.9600
-19,533.6830
-30,219.4540
-16,453.3240
Basic EPS
-1.61
-1.66
-2.26
-3.99
-2.63
Diluted EPS
-1.61
-1.66
-2.26
-3.99
-2.63
Basic Average Shares
8,854.1060
8,991.7660
8,659.7180
7,574.9530
6,253.8290
Diluted Average Shares
8,854.1060
8,991.7660
8,659.7180
7,574.9530
6,253.8290
Total Operating Income as Reported
-5,750.6280
-8,828.2690
-15,409.7110
--
--
Total Expenses
18,370.5000
20,891.6140
25,048.7680
24,387.0720
16,736.5610
Net Income from Continuing & Discontinued Operation
-12,246.8490
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
Normalized Income
-11,673.3380
-14,104.0600
-18,174.2700
-28,446.9180
-15,900.0480
Interest Expense
5,629.6680
5,191.7230
2,582.6180
10,569.5930
2,481.1550
Net Interest Income
-5,629.6680
-5,191.7230
-2,582.6180
-10,569.5930
-2,481.1550
EBIT
-6,617.1810
-8,902.5600
-16,075.5250
-18,560.8840
-13,010.0210
EBITDA
-6,611.2280
-8,896.6070
-16,069.5720
-18,558.5760
-13,010.0210
Reconciled Cost of Revenue
3,357.2310
3,707.0640
4,197.0240
3,080.1160
2,112.0350
Reconciled Depreciation
5.9530
5.9530
5.9530
2.3080
--
Net Income from Continuing Operation Net Minority Interest
-12,246.8490
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
Total Unusual Items Excluding Goodwill
-573.5110
9.7770
-483.8730
-683.5590
408.8720
Total Unusual Items
-573.5110
9.7770
-483.8730
-683.5590
408.8720
Normalized EBITDA
-6,037.7170
-8,906.3840
-15,585.6990
-17,875.0170
-13,418.8930
3/31/2021 - 2/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSGM BioSig Technologies, Inc.
0.9200
+9.97%
NMTC NeuroOne Medical Technologies Corporation
0.6520
+8.04%
BBLG Bone Biologics Corporation
0.6801
-1.43%
6FA.BE Semler Scientific Inc
32.40
+5.88%
KLYG Kelyniam Global, Inc.
0.1500
0.00%
AEMD Aethlon Medical, Inc.
0.3813
+1.71%
XTNT Xtant Medical Holdings, Inc.
0.5100
+6.25%
HSDT Helius Medical Technologies, Inc.
0.2920
-2.24%
TMCI Treace Medical Concepts, Inc.
6.72
+0.90%
AHCO AdaptHealth Corp.
8.41
+4.73%